Regeneron and Sanofi To Accelerate and Expand Investment for Cemiplimab and Dupilumab Development Programs

Monday, January 8, 2018 1 min read

Key Takeaway: Regeneron and Sanofi To Accelerate and Expand Investment for Cemiplimab and Dupilumab Development Programs

Full Press Release Details

Regeneron and Sanofi To Accelerate and Expand Investment for Cemiplimab and Dupilumab Development Programs.